Experimentica Ltd Announces a Strategic Partnership with the Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland

Kuopio, Finland, November 19, 2014 --(PR.com)-- Experimentica Ltd., a Finland-based ophthalmic CRO, announces a strategic partnership with The Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland. SILK is a research network composed of research units engaged in basic and clinical eye and vision research. Dr. Giedrius Kalesnykas, Founder and CEO of Experimentica Ltd.: “We are delighted to have a strategic partner with strong expertise in clinical research such as ocular pharmacology and proteomics, refractive surgery, retinal imaging and ocular implants. Experimentica Ltd. focuses on preclinical in vitro, ex vivo and in vivo models for eye diseases. However, through this strategic partnership our clients will have an opportunity to look beyond preclinical phase and utilize the whole pipeline of drug discovery with Phase 1-4 clinical studies.”

Experimentica Ltd. is a preclinical CRO offering an industry leading portfolio of ocular models and services. Finland is a Nordic country in Northern Europe, which is known for innovations in science and technology.